香港股市 已收市

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
86.81+0.64 (+0.74%)
收市:04:00PM EDT
86.81 0.00 (0.00%)
收市後: 05:49PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價86.17
開市85.70
買盤86.64 x 300
賣出價86.89 x 200
今日波幅85.64 - 87.59
52 週波幅85.21 - 125.83
成交量1,577,514
平均成交量641,574
市值20.92B
Beta 值 (5 年,每月)0.23
市盈率 (最近 12 個月)21.33
每股盈利 (最近 12 個月)4.07
業績公佈日2024年5月06日
遠期股息及收益率無 (無)
除息日2022年6月02日
1 年預測目標價118.42
  • InvestorPlace

    The 3 Best Bargain Stocks to Buy in Q2 2024

    Best bargain stocks to buy is a simple but tricky concept. Whenever shares trade lower than an established multiple, whether that by earnings, sales, book or some other metric, there might be a reason for it. In many cases, it’s not a good one. Let’s face reality here. In the age of the internet, it’s difficult for a well-known publicly traded enterprise to be woefully undervalued. That’s because information is readily available. If the market genuinely believed there was value to be extracted,

  • InvestorPlace

    3 Biotech Stocks to Buy for the Next Bull Run: March 2024

    As we step into March 2024, the spotlight is turning towards the biotech sector, with investors searching for biotech stocks to buy. Biotech stocks are ready to soar after a period of under-performance relative to the broader market. With advancements in gene editing, personalized medicine and novel therapeutics, the sector is on the cusp of delivering transformative healthcare solutions. The global biotechnology market is set for remarkable growth. It is forecast to soar from $1 trillion in 202

  • Barrons.com

    This Vaccine Maker Sits on Cash Almost Equal to Its Market Value

    This biotechnology company has nearly 90% of its market value in cash and investments but is being shunned by investors even as they gravitate to the sector this year. The company is BioNTech (Ticker BNTX). It partnered with Pfizer to produce the leading Covid vaccine, Comirnaty, whose original messenger RNA technology was developed by BioNTech.